QUANTITATIVE DETERMINATION OF HOST CELL PROTEINS (CHO) BY THE METHOD OF ENZYME IMMUNOASSAY IN THE PROTEIN ADALIMUMAB
Is necessary to ensure thorough purification of the target proteins, since the presence of host cell proteins (HCP) from CHO cells in the final product is fraught with a number of negative consequences. Thus, it is has to reduce the contamination of HCP to minimum levels. A comparison of the immunoe...
Main Authors: | P. M. Isaykina, V. P. Dolgova, A. D. Ascretcov, N. V. Orlova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-01-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/513 |
Similar Items
-
Immunoassay Detection of SARS‐CoV‐2 Using Monoclonal Antibody Binding to Viral Nucleocapsid Protein
by: Robert M. Hnasko, et al.
Published: (2025-02-01) -
Monoclonal antibody-based immunoassay for the specific quantification of licochalcone A: an active chalcone in licorice
by: Supaluk Krittanai, et al.
Published: (2022-12-01) -
Development of a highly sensitive and specific monoclonal antibody-based immunoassay for detection of okadaic acid in oysters and green mussels
by: Cheng Liang, et al.
Published: (2022-12-01) -
ELISA and Chemiluminescent Enzyme Immunoassay for Sensitive and Specific Determination of Lead (II) in Water, Food and Feed Samples
by: Long Xu, et al.
Published: (2020-03-01) -
Volume and trends of adalimumab and pembrolizumab reimbursed market: the Bulgarian perspective
by: Maria Kamusheva, et al.
Published: (2021-01-01)